-
Viatris Inc. today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug Application for abacavir 60 mg/dolutegravir 5 mg/lamivudine 30 mg tablets for oral suspension for the treatment of HIV-1 infection in paediatric patients.
-
Viatris Inc. and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application approved by the U.S. Food and Drug Administration (FDA).
-
Dec 29, 2022 9:00 AM ET - Abbott announced the U.S. Food and Drug Administration approval of the company's Eterna™, – the smallest implantable, rechargeable spinal cord stimulator currently available on the market for the treatment of chronic pain...
-
The three-day event returns to fully in-person for the first time in more than three years, featuring 200+ speakers, including government officials, philanthropists, scientists, and more
-
Physicians prescribe medication and design treatment and therapy plans for their patients based on the most recent clinical trial research available, much of which is utilized by the U.S. Food and Drug Administration to evaluate safety and efficacy.
-
Analysis of randomized controlled trial data shows non-Caucasian high-risk PCI patients significantly benefit from Impella-support
-
Event will Highlight and Explore Collaborative Efforts to Overcome Inequities Faced by Minoritized Communities
-
Quest Diagnostic announced that it has received emergency use authorization from the U.S. Food and Drug Administration for the company's lab-developed molecular diagnostic test to aid in the diagnosis of infection with the Monkeypox virus.
-
Report Aligned with Leading Sustainability Frameworks and Elanco’s Healthy Purpose™ Sustainability Approach
-
Around three-quarters of nicotine consumers want policymakers to consider their views when deliberating on tobacco and nicotine regulations
-
Merck and Ridgeback Biotherapeutics announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for molnupiravir, an investigational oral antiviral (MK-4482, EIDD-2801).
-
AIDS Healthcare Foundation (AHF) praised today Merck and Ridgeback Biotherapeutics for granting a royalty-free license to manufacture their COVID-19 antiviral drug molnupiravir in more than 100 developing countries. AHF calls on Moderna, Pfizer, and Johnson & Johnson to follow Merck’s example and voluntarily grant royalty-free manufacturing and distribution rights for their COVID-19 vaccines and facilitate technology transfers to expand generic vaccine production around the world. “If Merck
-
Publishes Low-Carbon Transition Plan with updated targets and detailed strategy to decarbonize its direct operations by 2025 and to achieve net-zero emissions across its entire value chain by 2040
-
Guests who show valid COVID-19 vaccination card Aug. 30 through Sept. 5 will receive two free doughnuts any time, every day, and one free doughnut daily for rest of year
-
SOURCE: O-I Glass, Inc. DESCRIPTION:Lightweight. Source reduction. Less fuel during transportation. We’ve all heard these attributes associated with sustainability marketing claims, or justifications for changing packaging materials. Today’s sustainability dialogue would have you believe the sustainability “paradigm” has shifted and is defined by success on single issues. But sustainability is not a one-issue, one-variable, linear measurement or characteristic. That’s the message O-I Glass, Inc.
-
Abbott announced today that the U.S. Food and Drug Administration (FDA) has cleared the FreeStyle® Libre 2 iOS application for use with compatible iPhones1, providing a comprehensive digital offering for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system.
-
Elanco to invest $150,000 through 2023 to support grassland restoration
-
Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW™ COVID-19 Ag Self Test for detection of COVID-19 infection.
-
On International Women’s Day, Philip Morris International Inc. (PMI) (NYSE: PM) announced the launch of a yearlong research and convening initiative entitled “Inclusive Future.” Following a year when inclusion and diversity efforts moved center stage amid the global pandemic, the absence of a single authoritative approach to effectively measure inclusion in business has become even more apparent. To address this need, PMI’s Inclusive Future initiative will explore best practices and established
-
Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2021 Full-Year Earnings Guidance
-
-
Altria prices cash tender offers for an aggregate purchase price of $4.623 billion, excluding accrued interest, in respect of certain of its outstanding senior unsecured notes.
-
Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved updated labeling for the company's HeartMate 3™ heart pump to be used in pediatric patients with advanced refractory left ventricular heart failure.
-
Today we’re pleased to say that our widely-used BinaxNOW rapid test, the size of a credit card and requiring no instrumentation, has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for use at home with a prescription through a virtually guided online service.
-
FDA Authorizes Ecolab's Bioquell Technology System for N95 Respirator Decontamination Fri, 12/18/2020 - 09:30 Subheader Ecolab’s decontamination technology enables respirator reuse by healthcare personnel to help address shortages Type of Content Press Release Layout Standard Format Body ST. PAUL, Minn. – December 18, 2020 /3BL Media/ – Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources, has received Emergency
-
PMI Named in Dow Jones Sustainability North American Index; the Company Continues to Demonstrate Progress Toward Delivering a Smoke-Free World
-
Nonprofit Will Enable Access to Proprietary SHERLOCK™ CRISPR-based Technology to Support Third-party Development of COVID-19 Diagnostic Tests
Proceeds to Support Racial and Gender Diversity in STEM
-
SOURCE: Gilead Sciences DESCRIPTION:After receiving the green light from the FDA to move forward, Gilead is about to start trials of an inhaled version of remdesivir. We will screen healthy volunteers for Phase 1 trials this week and hope to begin studies in patients with COVID-19 in August. If the trials are successful, this could represent important progress. Remdesivir, our investigational antiviral medicine, is currently given to patients intravenously through daily infusions in the hospital.
-
-
Specialized polypropylene monthly production increased by 1,000 tonnes; enough to make 200 million masks or 20 million gowns
-
Isopropyl alcohol monthly production increased by up to 3,000 tonnes; enough to make 50 million bottles of hand sanitizer
-
ExxonMobil lending expertise to redesign and manufacture reusable masks, shields
-
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”), one of the largest U.S.-based generics manufacturers, and the State of Texas today announced that they are responding to the national COVID-19 health emergency. Amneal has donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State Pharmacy, which will be directly distributed to hospitals for potential use in treating COVID-19 patients. “On behalf of the people of Texas, I thank Amneal for this generous donation,”
-
-- NFL Draft Prospects Participating in ‘Reps for Rare Disease’ Will Help Raise Funds for Research and Awareness Programs --
-- Horizon will match Pledged Donations Through the Company’s #RAREis Program --
-
Local Blood Center Helps Bring in Hundreds of Donors
-
Grant Reflects Ancestry’s Focus on Working with Providers, Consumers Toward Improved Health Outcomes
-
The Blood Connection to Host Blood Drive Week of July 4
-
AptarGroup, Inc. (NYSE: ATR) announced today that it has signed the New Plastics Economy Global Commitment and has joined forces with other businesses and governments committed to changing how we produce, use and reuse plastic. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190118005043/en/ Photo: New Plastics Economy The Global Commitment, through the Ellen MacArthur Foundation, has mobilized over 250 signatories that are determined
-
“REKOOP” is the first Bedding solution to use Applied DNA’s CertainT
Platform and Reliance Industries’ Recron GreenGold fiber for source
verification and traceability of recycled polyester across the supply
chain; Arrives in US Q1 2019
-
-- Landmark Just Scramble product begins rolling out
-- New funding announced to scale Just Scramble
-- Just product choices bring huge water savings, smaller carbon
footprint
-
-
Supporting Baxter employees and communities with humanitarian aid
and supplies
-
Resumed limited production at all Puerto Rico manufacturing sites
-
Activated global manufacturing facilities to help support product
supply for U.S.
-
Company expects to mitigate earnings impact from Hurricane Maria
-
May 5, 2016 11:00 AM ET - WASHINGTON, DC, May 5, 2016 /3BL Media/ – As the U.S. Food and Drug Administration considers issuing voluntary guidelines on sodium levels in packaged food, Nestlé S.A. has taken another significant step in the company’s journey to support public...